Trelstar (triptorelin pamoate) for Injectable Suspension Single-Dose Vial (NDC 52544-154-02) plus...

FDA Recall #D-1085-2014 — Class II — December 9, 2013

Recall #D-1085-2014 Date: December 9, 2013 Classification: Class II Status: Terminated

Product Description

Trelstar (triptorelin pamoate) for Injectable Suspension Single-Dose Vial (NDC 52544-154-02) plus MIXJECT Single-Dose Delivery System containing 2 mL Sterile Water for Injection, USP per carton (NDC 52544-188-76), 11.25 mg, Rx Only, Dist. By: Watson Pharma, Inc., Morristown, NJ 07962, Mfd. by: Debio RP, CH-1920 Martigny, Switzerland.

Reason for Recall

Labeling: Label Error On Declared Strength: Trelstar 11.25 mg labeled carton/kit contained a vial labeled as 3.75 mg instead of a vial being labeled as 11.25mg.

Recalling Firm

Actavis Inc — Parsippany, NJ

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

99 cartons

Distribution

Nationwide and Puerto Rico

Code Information

Lot #: 13J081, Exp 05/15

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated